pmc logo imageJournal ListSearchpmc logo image
Logo of thoraxJournal URL: redirect3.cgi?&&auth=0Nm7Iy8b3BCI3G-xNg-paECxvUwUbupQtoO1MmkGL&reftype=publisher&artid=462157&article-id=462157&iid=14521&issue-id=14521&jid=179&journal-id=179&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://thorax.bmj.com/
Journal List > Thorax > v.44(11); Nov 1989
>Summary
Selected References
Page Browse
PDF (1.2M)
Contents
Archive

PubMed articles by:
Pinching, A.
Thorax. 1989 November; 44(11): 971–977.
PMCID: PMC462157
Copyright notice
AIDS and the lung. 2--Antiretroviral treatment in human immunodeficiency virus disease.
A J Pinching
Department of Clinical Immunology, St Mary's Hospital Medical School, London.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 971
971
icon of scanned page 972
972
icon of scanned page 973
973
icon of scanned page 974
974
 
icon of scanned page 975
975
icon of scanned page 976
976
icon of scanned page 977
977
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Pinching, AJ. Current issues in the management of AIDS patients. J Acquir Immune Defic Syndr. 1988;1(6):583–592. [PubMed]
  • Pinching, AJ. Factors affecting the natural history of human immunodeficiency virus infection. Immunodefic Rev. 1988;1(1):23–38. [PubMed]
  • Wofsy, CB. AIDS care: providing care for the HIV infected. J Acquir Immune Defic Syndr. 1988;1(3):274–283. [PubMed]
  • Glatt, AE; Chirgwin, K; Landesman, SH. Current concepts. Treatment of infections associated with human immunodeficiency virus. N Engl J Med. 1988 Jun 2;318(22):1439–1448. [PubMed]
  • Gold, JW. Infectious complications in patients with HIV infection. AIDS. 1988 Oct;2(5):327–334. [PubMed]
  • Pinching, AJ. Prophylactic and maintenance therapy for opportunist infections in AIDS. AIDS. 1988 Oct;2(5):335–343. [PubMed]
  • Mitsuya, H; Weinhold, KJ; Furman, PA; St Clair, MH; Lehrman, SN; Gallo, RC; Bolognesi, D; Barry, DW; Broder, S. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci U S A. 1985 Oct;82(20):7096–7100. [PubMed]
  • Yarchoan, R; Klecker, RW; Weinhold, KJ; Markham, PD; Lyerly, HK; Durack, DT; Gelmann, E; Lehrman, SN; Blum, RM; Barry, DW, et al. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet. 1986 Mar 15;1(8481):575–580. [PubMed]
  • Fischl, MA; Richman, DD; Grieco, MH; Gottlieb, MS; Volberding, PA; Laskin, OL; Leedom, JM; Groopman, JE; Mildvan, D; Schooley, RT, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. [PubMed]
  • Yarchoan, R; Berg, G; Brouwers, P; Fischl, MA; Spitzer, AR; Wichman, A; Grafman, J; Thomas, RV; Safai, B; Brunetti, A, et al. Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine. Lancet. 1987 Jan 17;1(8525):132–135. [PubMed]
  • Jackson, GG; Paul, DA; Falk, LA; Rubenis, M; Despotes, JC; Mack, D; Knigge, M; Emeson, EE. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT). Ann Intern Med. 1988 Feb;108(2):175–180. [PubMed]
  • de Gans, J; Lange, JM; Derix, MM; de Wolf, F; Eeftinck Schattenkerk, JK; Danner, SA; Ongerboer de Visser, BW; Cload, P; Goudsmit, J. Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine. AIDS. 1988 Feb;2(1):37–40. [PubMed]
  • Pinching, AJ; Helbert, M; Peddle, B; Robinson, D; Janes, K; Gor, D; Jeffries, DJ; Stoneham, C; Mitchell, D; Kocsis, AE, et al. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex. J Infect. 1989 Jan;18 Suppl 1:33–40. [PubMed]
  • Williams, I; Gabriel, G; Cohen, H; Williams, P; Tedder, RS; Machin, S; Weller, IV. Zidovudine--the first year of experience. J Infect. 1989 Jan;18 Suppl 1:23–31. [PubMed]
  • Stambuk, D; Hawkins, D; Gazzard, BG. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience. J Infect. 1989 Jan;18 Suppl 1:41–51. [PubMed]
  • Richman, DD; Andrews, J. Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection. Am J Med. 1988 Aug 29;85(2A):208–213. [PubMed]
  • Pizzo, PA; Eddy, J; Falloon, J; Balis, FM; Murphy, RF; Moss, H; Wolters, P; Brouwers, P; Jarosinski, P; Rubin, M, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med. 1988 Oct 6;319(14):889–896. [PubMed]
  • Larder, BA; Darby, G; Richman, DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 1989 Mar 31;243(4899):1731–1734. [PubMed]
  • Schmitt, FA; Bigley, JW; McKinnis, R; Logue, PE; Evans, RW; Drucker, JL. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1988 Dec 15;319(24):1573–1578. [PubMed]
  • Hymes, KB; Greene, JB; Karpatkin, S. The effect of azidothymidine on HIV-related thrombocytopenia. N Engl J Med. 1988 Feb 25;318(8):516–517. [PubMed]
  • Ragni, MV; Tama, G; Lewis, JH; Ho, M. Increased frequency of haemarthroses in haemophilic patient treated with zidovudine. Lancet. 1988 Jun 25;1(8600):1454–1455. [PubMed]
  • Bessen, LJ; Greene, JB; Louie, E; Seitzman, P; Weinberg, H. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N Engl J Med. 1988 Mar 17;318(11):708. [PubMed]
  • Necrotising myopathy and zidovudine. Lancet. 1988 May 7;1(8593):1050–1051. [PubMed]
  • Helbert, M; Fletcher, T; Peddle, B; Harris, JR; Pinching, AJ. Zidovudine-associated myopathy. Lancet. 1988 Sep 17;2(8612):689–690. [PubMed]
  • Grimm, G; Ferenci, P; Katzenschlager, R; Madl, C; Schneeweiss, B; Laggner, AN; Lenz, K; Gangl, A. Improvement of hepatic encephalopathy treated with flumazenil. Lancet. 1988 Dec 17;2(8625):1392–1394. [PubMed]
  • Azidothymidine in the treatment of AIDS. N Engl J Med. 1988 Jan 28;318(4):250–251. [PubMed]
  • Helbert, M; Robinson, D; Peddle, B; Forster, S; Kocsis, A; Jeffries, D; Pinching, AJ. Acute meningo-encephalitis on dose reduction of zidovudine. Lancet. 1988 Jun 4;1(8597):1249–1252. [PubMed]
  • Loke, RH; Wade, JP; Murray-Lyon, IM. Myelopathy after stopping zidovudine. Lancet. 1988 Jul 30;2(8605):279. [PubMed]
  • de Wolf, F; Lange, JM; Goudsmit, J; Cload, P; de Gans, J; Schellekens, PT; Coutinho, RA; Fiddian, AP; van der Noordaa, J. Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects. Lancet. 1988 Feb 20;1(8582):373–376. [PubMed]
  • Bach, MC. Zidovudine for lymphocytic interstitial pneumonia associated with AIDS. Lancet. 1987 Oct 3;2(8562):796. [PubMed]
  • Helbert, M; Stoneham, C; Mitchell, D; Pinching, AJ. Zidovudine for lymphocytic interstitial pneumonitis in AIDS. Lancet. 1987 Dec 5;2(8571):1333–1333. [PubMed]
  • Yarchoan, R; Perno, CF; Thomas, RV; Klecker, RW; Allain, JP; Wills, RJ; McAtee, N; Fischl, MA; Dubinsky, R; McNeely, MC, et al. Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet. 1988 Jan 16;1(8577):76–81. [PubMed]
  • Farthing, CF; Dalgleish, AG; Clark, A; McClure, M; Chanas, A; Gazzard, BG. Phosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complex. AIDS. 1987 May;1(1):21–25. [PubMed]
  • Gaub, J; Pedersen, C; Poulsen, AG; Mathiesen, LR; Ulrich, K; Lindhardt, BO; Faber, V; Gerstoft, J; Hofmann, B; Lernestedt, JO, et al. The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients. AIDS. 1987 May;1(1):27–33. [PubMed]
  • Bergdahl, S; Sönnerborg, A; Larsson, A; Strannegard, O. Declining levels of HIV P24 antigen in serum during treatment with foscarnet. Lancet. 1988 May 7;1(8593):1052–1052. [PubMed]
  • de Wit, R; Schattenkerk, JK; Boucher, CA; Bakker, PJ; Veenhof, KH; Danner, SA. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma. Lancet. 1988 Nov 26;2(8622):1214–1217. [PubMed]
  • Lane, HC; Kovacs, JA; Feinberg, J; Herpin, B; Davey, V; Walker, R; Deyton, L; Metcalf, JA; Baseler, M; Salzman, N, et al. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet. 1988 Nov 26;2(8622):1218–1222. [PubMed]
  • Brook, MG; Gor, D; Forster, SM; Harris, W; Jeffries, DJ; Thomas, HC. Suppression of HIV p24 antigen and induction of HIV anti-p24 antibody by alpha interferon in patients with chronic hepatitis B. AIDS. 1988 Oct;2(5):391–393. [PubMed]
  • Orholm, M; Pedersen, C; Mathiesen, L; Dowd, P; Nielsen, JO. Suppression of p24 antigen in sera from HIV-infected individuals with low-dose alpha-interferon and zidovudine: a pilot study. AIDS. 1989 Feb;3(2):97–100. [PubMed]
  • Smith, DH; Byrn, RA; Marsters, SA; Gregory, T; Groopman, JE; Capon, DJ. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science. 1987 Dec 18;238(4834):1704–1707. [PubMed]
  • Fisher, RA; Bertonis, JM; Meier, W; Johnson, VA; Costopoulos, DS; Liu, T; Tizard, R; Walker, BD; Hirsch, MS; Schooley, RT, et al. HIV infection is blocked in vitro by recombinant soluble CD4. Nature. 1988 Jan 7;331(6151):76–78. [PubMed]
  • Hussey, RE; Richardson, NE; Kowalski, M; Brown, NR; Chang, HC; Siliciano, RF; Dorfman, T; Walker, B; Sodroski, J; Reinherz, EL. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature. 1988 Jan 7;331(6151):78–81. [PubMed]
  • Deen, KC; McDougal, JS; Inacker, R; Folena-Wasserman, G; Arthos, J; Rosenberg, J; Maddon, PJ; Axel, R; Sweet, RW. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature. 1988 Jan 7;331(6151):82–84. [PubMed]
  • Traunecker, A; Lüke, W; Karjalainen, K. Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature. 1988 Jan 7;331(6151):84–86. [PubMed]
  • Capon, DJ; Chamow, SM; Mordenti, J; Marsters, SA; Gregory, T; Mitsuya, H; Byrn, RA; Lucas, C; Wurm, FM; Groopman, JE, et al. Designing CD4 immunoadhesins for AIDS therapy. Nature. 1989 Feb 9;337(6207):525–531. [PubMed]
  • Jackson, GG; Perkins, JT; Rubenis, M; Paul, DA; Knigge, M; Despotes, JC; Spencer, P. Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS. Lancet. 1988 Sep 17;2(8612):647–652. [PubMed]
  • Karpas, A; Hill, F; Youle, M; Cullen, V; Gray, J; Byron, N; Hayhoe, F; Tenant-Flowers, M; Howard, L; Gilgen, D, et al. Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9234–9237. [PubMed]
Articles from Thorax are provided here courtesy of
BMJ Group